Navigation Links
BD Announces Acquisition of Cytopeia
Date:5/13/2008

Expands Portfolio of Advanced Flow Cytometry Platforms

FRANKLIN LAKES, N.J., May 13 /PRNewswire-FirstCall/ -- BD (Becton, Dickinson and Company) (NYSE: BDX) announced today that it has acquired all of the outstanding stock of Cytopeia, a privately held Washington corporation based in Seattle that develops and markets advanced flow cytometry cell sorting instruments.

Financial terms of this transaction were not disclosed. The acquisition is not expected to have a material impact on BD's fiscal year 2008 earnings.

"This strategic acquisition brings new technologies and capabilities that will enhance BD's ability to address growing customer needs in advanced applications, such as cell therapy research," said William A. Kozy, BD Executive Vice President. "This transaction reflects our commitment to bringing innovative tools to life scientists and will allow us to rapidly enter emerging areas of cell-based research."

Cytopeia's Influx(TM) cell sorter offers BD an open, configurable cell sorting platform that can be fully optimized for researchers' unique application-specific requirements. This high level of choice and control is particularly important for life science research on the leading edge of biomedical discovery. The Influx cell sorter is suited for a range of applications including cell therapy research, stem cell research, drug discovery and development, as well as marine biology. It complements the BD FACSAria(TM) II system -- the platform of choice in research labs around the world for a broad range of immunology cell sorting and multi-color applications.

Through the acquisition, BD gains the scientific leadership and insights of Dr. Ger van den Engh, a renowned innovator in flow cytometry.
'/>"/>

SOURCE BD (Becton, Dickinson and Company)
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Chindex International Announces Shelf Registration, Related Strategy and Guidance
2. Amicus Therapeutics Announces First Quarter 2008 Financial Results
3. Chindex International Announces Conference Call to Discuss Its Fiscal 2008 Fourth Quarter and Year End Results on Thursday, June 12, 2008
4. Jazz Pharmaceuticals, Inc. Announces First Quarter 2008 Financial Results
5. China Sky One Medical, Inc. Announces Record First Quarter 2008 Results
6. Synvista Therapeutics Announces Initiation of the BREAK Study of Alagebrium for Diastolic Heart Failure
7. Palatin Technologies Announces New Strategic Objectives and Reports Third Quarter 2008 Financial Results
8. SGX Pharmaceuticals Announces First Quarter Financial Results and Gives Pipeline Update
9. Aton Pharma Announces Distribution Partnership in Brazil
10. China Medicine Announces Solid First Quarter 2008 Results
11. Volcano Announces Placement of 1,000th s5 and s5i IVUS Imaging System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... Patheon Inc ., a leading provider of contract development ... host a complimentary webinar on “Cleaning Validation: Science, Risk ... 2013 at 11 a.m. Eastern Standard Time. , ... for cleaning validation. Many companies have incorporated their ... of risk. Some companies have chosen to avoid ...
(Date:5/23/2013)... 2013 VG Energy, an agricultural biotech ... Renewable Research to conduct field trials using LipidMax ... is a majority owned subsidiary of VG Life ... Energy,s exclusively licensed compound LipidMax selectively inhibits certain ... plants, possessing a wide variety of applications including ...
(Date:5/23/2013)... 23, 2013 Z Trim Holdings, Inc. (OTC ... a variety of industries, announced that Chef ... at this year,s National Restaurant Association ("NRA") NRA Show, ... of the Research Chefs Association.  Chef Ryan spoke on ... the Bad and the Ugly," joining four other prestigious ...
(Date:5/23/2013)... May 23, 2013 During the ... critical to adhere to principles of good clinical ... Esteemed speaker Dr. Jeremy Lim, Fellow, Clinical Development ... ,     Understand the International Conference on ... and additional regulations for the conduction of clinical ...
Breaking Biology Technology:Patheon to Present on “Cleaning Validation: Science, Risk and Novel Approaches to Testing” 2VG Energy Enters into a Strategic Alliance with DAK Renewable Research for LipidMax Field Trials 2VG Energy Enters into a Strategic Alliance with DAK Renewable Research for LipidMax Field Trials 3Z Trim's Chef Erin Ryan sits on Expert Panel at NRA Show 2Z Trim's Chef Erin Ryan sits on Expert Panel at NRA Show 3Adhering to Good Clinical Practice, New Webinar Hosted by Xtalks 2
... IL-8 and Future ... in Cancer and Inflammation, COPENHAGEN, September 13 ... antibody is directed,to IL-8 (interleukin-8) and may have potential ... studies to treat glioblastoma,a cancer of the central nervous ...
... - Physicians Welcome New Option ... has a Rapidly Bactericidal Mode of Action ... treatment of both,methicillin-sensitive and resistant Staphylococcus aureus ... infections (right-sided,infective endocarditis) has been announced today ...
... Named 2007 Medical Products Industry Leader, DEERFIELD, Ill., ... announced today that it has been named 2007,Medical Products ... World) and the Dow Jones Sustainability North America Index,(DJSI ... the,company has been listed in the DJSI and the ...
Cached Biology Technology:Genmab Discloses Target and Development Plans for HuMax-Inflam 2Genmab Discloses Target and Development Plans for HuMax-Inflam 3New Licence for Cubicin(R) (daptomycin), the First in a Novel Class of Antibiotic, is Announced Today for the Treatment of Serious Bloodstream and Heart Infections Caused by the Most Problematic UK Organisms, Including MRSA 2New Licence for Cubicin(R) (daptomycin), the First in a Novel Class of Antibiotic, is Announced Today for the Treatment of Serious Bloodstream and Heart Infections Caused by the Most Problematic UK Organisms, Including MRSA 3New Licence for Cubicin(R) (daptomycin), the First in a Novel Class of Antibiotic, is Announced Today for the Treatment of Serious Bloodstream and Heart Infections Caused by the Most Problematic UK Organisms, Including MRSA 4Baxter Named to Dow Jones Sustainability Index for Ninth Consecutive Year 2
(Date:5/23/2013)... mechanism by which estrogen suppresses lipid synthesis in the ... approach toward treating certain liver diseases. , With ... are changing long-held views in the field. Study results ... Science Signaling . , "The dogma in the ... only receptors located in the nucleus respond to steroid ...
(Date:5/23/2013)... unnecessarily undergo surgery or harsh treatments because science ... aggressive forms of the disease. Researchers at Case ... are developing technology that allows patients to safely ... treatments or take drastic measures. , The project ... professor of biomedical engineering at Case Western Reserve ...
(Date:5/23/2013)... of the world are billions of animal and plant ... and grasses, all stacked, stored and preserved in jars ... could be critical to understanding how the Earth,s biodiversity ... footprint if only the information were easily accessible. ... the help of a team from the University of ...
Breaking Biology News(10 mins):UCI study reveals new mechanism for estrogen suppression of liver lipid synthesis 2Using big data to identify prostate cancers and best treatments 2Using big data to identify prostate cancers and best treatments 3CU-Boulder helps tap crowds to digitize museum records of bugs and plants 2CU-Boulder helps tap crowds to digitize museum records of bugs and plants 3CU-Boulder helps tap crowds to digitize museum records of bugs and plants 4
... . . Changing the behavior of a material ... the computing power of Oak Ridge National Laboratory,s Jaguar supercomputer, ... and hydrogen to nanoribbons made of boron nitride. The added ... insulator into that of a metal. That makes ...
... hot springs are furthering efforts at the Department of ... from crops such as switchgrass. The ... expensive enzymes that break down complex plant materials to ... cheaper alternative is consolidated bioprocessing, a streamlined process that ...
... study is revealing new information about a key protein,s ... neurological disorders. This work could one day lead to ... associate professor in The University of Texas at Dallas, ... with senior neuroscience student Francisco Garcia on a series ...
Cached Biology News:ORNL story tips, February 2012 2ORNL story tips, February 2012 3ORNL explores proteins in Yellowstone bacteria for biofuel inspiration 2Study looks at possible link to hyper-excitability factors in epilepsy, autism and more 2
Human Cell Line Slides...
... Signet offers the most comprehensive, cost-effective ... We have incorporated unprecedented quality into ... This includes proven detection chemistries and ... the TechMate protocol. It also includes ...
... 2 Detection System combines the indirect ... principle and Signets unique formulation of ... and reliablility. Signet reagents will achieve ... and automated protocols. ,Signets USA Detection ...
... Each Signet Level 2 Detection System ... avidin-biotin chemical bonding principle and Signets ... provide sensitivity, specificity and reliablility. Signet ... in both manual and automated protocols. ...
Biology Products: